Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Scalp sarcoidosis can cause hair loss and needs accurate diagnosis and treatment with specific medications.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Some cancer treatments can cause permanent hair loss.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

Trichoscopy helps diagnose hair and scalp disorders in dark-skinned people by identifying unique patterns.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Early intervention and patient education are crucial for managing alopecia areata.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.